Seasonal influenza vaccines: Variability of immune responses to B lineage viruses
Authors:
Open Access
- 17 November 2024
- journal article
- review article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 20 (1) , 2421096
Abstract
Although influenza A viruses predominate globally, influenza B viruses are responsible for a significant and often underappreciated burden. Despite this, immunity to influenza B viruses remains understudied, and there is a perception that vaccine-mediated immune responses to influenza B strains are less robust than influenza A strains. This targeted literature review examines this concept using data from pivotal phase 3 immunogenicity studies on currently licensed seasonal influenza vaccines and explores several explanations for this phenomenon, including immune exposure history, assay limitations, virus-related properties inherent to B lineages, and strain mismatch. Overall, studies demonstrated vaccines induce variable and sometimes less robust immune responses to influenza B strains; however, further studies are needed to fully confirm and understand these observations. In identifying the potential causes of variable performance of current vaccines against influenza, this review aims to guide vaccine development to enhance overall vaccine performance and reduce disease burden worldwide.Keywords
Funding Information
- Moderna, Inc
This publication has 73 references indexed in Scilit:
- Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy TrialClinical and Vaccine Immunology, 2016
- The confounded effects of age and exposure history in response to influenza vaccinationVaccine, 2016
- Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trialInternational Journal of Infectious Diseases, 2015
- The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?Journal of Molecular Recognition, 2013
- Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 yearsBMC Infectious Diseases, 2013
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 YearsThe Journal of Infectious Diseases, 2013
- Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/YamagataThe Pediatric Infectious Disease Journal, 2011
- Structural basis for receptor specificity of influenza B virus hemagglutininProceedings of the National Academy of Sciences, 2007
- Variable efficacy of repeated annual influenza vaccinationProceedings of the National Academy of Sciences of the United States of America, 1999
- Ether treatment of type B influenza virus antigen for the hemagglutination inhibition testJournal of Clinical Microbiology, 1981